AzTrials
AzTrials

FatigueNCT07116161

Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in Singapore

A study testing Graded Exercise Therapy Arm (GET) and Experimental: Exercise Therapy (GET) plus Cognitive Behavioural Therapy (CBT) in people with Fatigue and Breast Cancer Female, run by National Cancer Centre, Singapore at 4 sites in Singapore.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this research study is to investigate the acceptability, feasibility, and effectiveness of exercise therapy and cognitive behavioral therapy (CBT) in improving fatigue levels and breast cancer treatment adherence in breast cancer patients. Read more about this study

Who is it for?
Ages 21 years and older, women only
Conditions the study is for
Fatigue, Breast Cancer Female
What is being tested?
Graded Exercise Therapy Arm (GET) and Experimental: Exercise Therapy (GET) plus Cognitive Behavioural Therapy (CBT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
4 sitesSingapore
Study dates
14 Jul 2025to 31 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Primary cohort (N=90):
  • Female
  • ≥21 years of age
  • Stage I-III breast cancer regardless of hormone receptor status or human epidermal growth factor receptor 2 (HER2) status
  • Completed surgery
  • Completed adjuvant chemotherapy, if indicated
Show all 18Show fewer
  • Reported fatigue (One-item fatigue scale score ≥ 4)
  • Ability to read and communicate in English
  • Willing to provide informed consent for the study participation
  • Exploratory cohort (N=10):
  • Female
  • ≥21 years of age
  • Stage IV breast cancer regardless of hormone receptor status or human epidermal growth factor receptor 2 (HER2) status
  • Completed surgery
  • Currently receiving systemic therapy (e.g. endocrine therapy, chemotherapy, targeted therapy or immunotherapy)
  • Reported fatigue (One-item fatigue scale score ≥ 4)
  • Ability to read and communicate in English
  • Willing to provide informed consent for the study participation

Who cannot join

  • Pregnant or lactating
  • Presence of dementia or major psychiatric disease
  • Deemed medically unsuitable by medical team for low to moderate intensity exercise
  • Unable or unwilling for tele-counselling sessions
  • Uncontrolled pain or undiagnosed pain
  • Low blood counts: Hb <8.0, Platelet <50K, ANC <1
Show all 10Show fewer
  • Electrolyte imbalances: K <3.0, Na <130
  • Cardiovascular diseases, including but not limited to: LVEF <35%, uncontrolled arrhythmias, severe coronary artery disease, severe valvular heart disease, uncontrolled hypertension etc. not cleared by a cardiologist
  • Active infection
  • Currently engaged in moderate to vigorous physical activity

Trial locations and contacts

4 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Dr Ryan Shea YC TAN, MBBS, MRCP(UK), MMed contact

+65 63065771

ryan.shea.tan.y.c@singhealth.com.sg

Michelle Chow contact

michelle.chow.t.n@nccs.com.sg

Singapore4 sites, 4 recruiting
  • National Cancer Centre, Singapore (NCCS)

    Singapore, 168583

    Dr Ryan Shea YC Tan, MBBS, MRCP(UK), MMed, +65 63065771, ryan.shea.tan.y.c@singhealth.com.sg

    Recruiting
  • Singapore General Hospital

    Singapore, 169608

    Dr Ramalingam Mothi Babu, MBBS, MRCP(UK), FAMS, FRCP, ramalingam.mothi.babu@singhealth.com.sg

    Recruiting
  • NCCS Satellite Clinic @ Changi General Hospital

    Singapore, 529889

    Dr Bernard JG CHUA, MBBS (Hons), MRCP(UK), bernard.chua.j.g@singhealth.com.sg

    Recruiting
  • NCCS Satellite Clinic @ Sengkang General Hospital

    Singapore, 544886

    Dr Jun MA, MBBS (Hons), ma.jun@singhealth.com.sg

    Recruiting

Other trials in Singapore

About this study

Official title: Pilot Study of Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in Singapore

The purpose of this research study is to investigate the acceptability, feasibility, and effectiveness of exercise therapy and cognitive behavioral therapy (CBT) in improving fatigue levels and breast cancer treatment adherence in breast cancer patients.

Read the detailed description

This is a randomized controlled, pilot intervention study enrolling 100 female breast cancer patients recruited from National Cancer Centre Singapore, Singapore General Hospital, NCCS Satellite Clinic @ Sengkang General Hospital, and NCCS Satellite Clinic @ Changi General Hospital.

Participants who are deemed eligible by their attending healthcare professional or indicate fatigue on the distress thermometer scale will be referred to the study research assistants or study investigators for further screening. Study research assistants or study investigators will use the Citrix SCM and OAS platform to review patient medical records and appointments.

The study research assistants or study investigators will screen participants based on the study's inclusion and exclusion criteria. They will then approach eligible participants during their clinic appointments or via telephone to introduce the study to them. Interested participants will be further screened and will be asked, "How would you rate your fatigue on a scale of 0 to10 with 0 being 'no fatigue' and 10 being the 'worst possible fatigue'?" (One-item fatigue scale score). The study research assistants or study investigators will record the one-item fatigue scale score for the healthcare professional to review.

If the participant is screened to be eligible, the consent process will be done in clinic or at the participant's home by research assistants and/or study investigators. This will take place either on the same day as their clinic appointment or at another mutually agreed upon date and time in a quiet and conducive room as far as possible. During the consent process, patients are given ample opportunity to ask questions. Participants will be given sufficient time to consider their willingness to participate in the study. Participation in the study will be entirely voluntary. All participants will provide written informed consent prior to their participation in the study.

After obtaining consent, recruited patients will be asked to complete the registration form. They will then be randomized 1:1 into either an exercise therapy arm or an exercise therapy plus CBT arm. They will then complete the baseline questionnaire and the 3 physical function tests, which will be conducted either by a rehabilitation professional, trained research assistant or study investigator. Afterwards, participants will commence the 12-week intervention they have been randomized into (exercise therapy or exercise therapy and CBT). Exercise therapy and CBT will each consist of up to four 1-hour telemedicine sessions using Zoom over 12 weeks, focusing on physical activity and psychosocial elements. The exercise therapy and CBT telemedicine sessions will be arranged at a mutually agreed upon date and time. Follow up visits will be conducted face-to-face in person at the study's site clinics or at the participant's home at a mutually agreed upon date and time at 3 months (Time 1), 6 months (Time 2) and 12 months post-enrolment (Time 3).

At each follow-up visit, the 3 physical function tests [i.e., 6-minute walk test (6MWT), Handgrip strength (HGS), and 5 times sit-to-stand test (5xSTS)] and corresponding follow-up questionnaire (Month 3, Month 6 and Month 12) will be administered by either a rehabilitation professional, trained research assistant or study investigator. The 6-Minute Walk Test (6MWT) is a submaximal exercise test that assesses walking endurance and aerobic capacity. Participants will walk a set circuit for six minutes, and the score is the total distance walked (in metres). The Hand Grip Strength (HGS) test measures isometric strength of the hand and forearm. Participants will sit comfortably with their forearm in a neutral position and elbow at a 90-degree angle, then squeeze a dynamometer as hard as possible with each hand. The average and maximum value (in kilograms) from three trials for each hand will be recorded. The Five Times Sit to Stand (5xSTS) test assesses lower limb strength. Participants will stand up and sit down five times as quickly as possible, and the score is the time (in seconds) to complete the repetitions. All questionnaires will be administered electronically using FormSG.

Exercise therapy will consist of a self-supervised individualized exercise prescription by the rehabilitation professional consisting of aerobic (e.g. brisk walking / cycling) and resistance training exercises, customized by patient preference. Note that exercise therapy is part of routine clinical care. However, conducting exercise therapy via teleconsulting, while occasionally done based on patient needs, is not considered part of routine clinical care. In the first session, an initial assessment and exercise prescription will be conducted, which will involve evaluating patient's fatigue, reviewing their medical history, setting personalized exercise goals, prescription of low-intensity exercise plan, education on monitoring fatigue and modifying exercises, and a review of the exercise booklet. The first review will take place in the second session, which will involve reviewing the exercise booklet, exercise adherence and fatigue levels, assessing progress in endurance and strength and adjustment of exercises accordingly. Any barriers to exercise and monitoring for new symptoms will also be discussed and addressed. The third and fourth session will be the same as in the second session. However, the fourth session will also cover long-term exercise recommendations and planning for continued independent exercise. The study's research assistants or study investigators will conduct weekly calls to check on adherence to exercises, compliance, and any difficulties or symptoms experienced. The information collected will be entered into a FormSG survey and accessed by rehabilitation professionals, who will provide feedback to the patient via email and/or call. Rehabilitation professional will do four follow-up reviews at each time point (week 0, 4, 8, and 12) during the 12-week intervention period to review the exercises and modify if required. The CBT intervention will have four major components adapted from previous studies and delivered by trained clinical psychologists or psychology trainees under supervision of a clinical psychologist. First, the model of CBT will be taught and applied to identify negative, unhelpful beliefs and the emotional, behavioural and physical consequences of those beliefs. Second, patients were taught behavioural strategies to manage fatigue (e g. sleep hygiene, activity scheduling). Lastly, participants will be guided to reformulate dysfunctional cognitions regarding fatigue, improve coping strategies in relation to significant others (e.g. family, friends) and set goals.

Being tested
Graded Exercise Therapy Arm (GET), Experimental: Exercise Therapy (GET) plus Cognitive Behavioural Therapy (CBT)
Keywords
Exercise Therapy, Cognitive Behavioural Therapy
Medical subject headings
Fatigue

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Graded Exercise Therapy Arm (GET)Other

    Consists of a self-supervised individualized exercise prescription by the rehabilitation professional consisting of aerobic (e.g. brisk walking / cycling) and resistance training exercises, customized by patient preference.

  • Experimental: Exercise Therapy (GET) plus Cognitive Behavioural Therapy (CBT)Other

    Consists of four major components adapted from previous studies,13,15,16 and delivered by qualified and trained study psychologists. First, the ABCD model of cognitive behavioural therapy (A: activating events, B: beliefs, C: consequences, D: Dispute) will be taught and applied to identify negative, unhelpful beliefs and the emotional, behavioural and physical consequences of those beliefs. Second, patients were taught behavioural strategies to manage fatigue (e.g. sleep hygiene, activity scheduling). Lastly, participants will be guided to reformulate dysfunctional cognitions regarding fatigue, improve coping strategies in relation to significant others (e.g. family, friends) and set goals.

Study groups in NCT07116161
Study groupRoleWhat they receive
Graded Exercise Therapy Arm (GET)ExperimentalNot described
Receives: Other: Graded Exercise Therapy Arm (GET)
Exercise Therapy (GET) plus Cognitive Behavioural Therapy (CBT)ExperimentalNot described
Receives: Other: Experimental: Exercise Therapy (GET) plus Cognitive Behavioural Therapy (CBT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Client Satisfaction with Exercise Therapy and Cognitive Behavioural Therapy (CBT)

    Measured using a 8-item Client Satisfaction Questionnaire. Each item is rated on a 4-point scale, with higher scores indicating greater satisfaction.

    Measured: Up to 12 months post-enrolment.

  2. Perceived Cultural Sensitivity of the Intervention

    Measured using 4 items adapted from the Cultural Sensitivity Assessment Tool. Each item is rated on a 4 point-scale (1 = Strongly Disagree, 4 = Strongly Agree) with higher scores indicating greater cultural sensitivity.

    Measured: Up to 12 months post-enrolment.

  3. Uptake and Adherence to Exercise Therapy and Cognitive Behavioural Therapy (CBT)

    Measured using the percentage of randomized patients who attended at least one session of their allocated intervention and the percentage of randomized patients who completed their allocated interventions.

    Measured: 3 Months post-enrolment.

  4. Willingness to Pay for Therapy Sessions

    • Measured using a 10-item custom survey based on a step-wise price-point method ($130, $100, $75, $50, $30 per session) to reflect a range of rates covering private and subsidized rates of different tiers.
    • Participants respond with binary Yes/No options, followed by questions assessing willingness to participate if costs are covered by Medisave.
    • This allows estimation of maximum willingness to pay under both cash and insurance-covered scenarios.

    Measured: 3 Months post-enrolment.

Secondary outcomes (7)
  1. Preliminary Effectiveness (Fatigue)

    Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) subscale evaluates changes in self-reported fatigue levels, a key symptom among breast cancer survivors. FACIT-F scores range from 0 to 52, with higher scores indicating less fatigue.

    Measured: Up to 12 months post-enrolment.

  2. Adherence to Breast Cancer Treatments

    5-item medication adherence survey adapted from prior studies measuring adherence to prescribed medications over the past 3 months. The primary measure item asks how often participants took their medication as prescribed over the past 3 months. Nonadherence is defined as 75% of the time or less. Additional items assess frequency of forgetting or intentionally skipping medications, with nonadherence defined as once per week or more. Two items address medication switching and discontinuation. Participants who skipped medications only due to switching between tamoxifen and aromatase inhibitors (AIs) will be considered adherent, while those who discontinued tamoxifen or an AI will be asked to provide reasons.

    Measured: Up to 12 months post-enrolment.

  3. Quality of Life (QoL)

    Functional Assessment of Cancer Therapy - General (FACT-G), assesses quality of life. FACT-G scores range from 0-108 with higher scores indicating better quality of life.

    Measured: Up to 12 months post-enrolment.

  4. Godin-Shephard Leisure-Time Physical Activity Questionnaire (GLTPAQ)

    Captures the frequency and intensity of participants' physical activity during their free time. GLTPAQ scores are calculated based on frequency and intensity of weekly leisure activity. A score of 24 or more indicates active, a score of 23 or less indicates insufficient activity.

    Measured: Up to 12 months post-enrolment.

  5. 6-Minute Walk Test (6MWT)

    Measures the distance (in metres) an individual can walk in six minutes as an indicator of walking endurance and aerobic capacity

    Measured: Up to 12 months post-enrolment.

  6. Handgrip Strength (HGS)

    The average and maximum value (in kilograms) from three trials for each hand. Measures the isometric strength of the hand and forearm

    Measured: Up to 12 months post-enrolment.

  7. 5 Times Sit-to-Stand Test (5xSTS)

    Measures the time (in seconds) it takes for a person to rise from a seated position to standing five times in succession, reflecting lower limb strength.

    Measured: Up to 12 months post-enrolment.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2025
  2. Study start14 Jul 2025
  3. Primary completion30 Apr 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07116161
Sponsor's protocol ID
2025-0016
Status last verified
May 2026
First submitted
7 Jul 2025
Last updated
29 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Fong JRE, Tan PL, Chow MTN, Ong WS, Teo I, Tan RSYC, Ramalingam MB. Graded Exercise Therapy and Cognitive Behavioral Therapy for Fatigue in Patients With Breast Cancer: Protocol for a Randomized Controlled Pilot Study. JMIR Res Protoc. 2026 Aug 7;15:e91330. doi: 10.2196/91330.

    PubMed 42566743

Questions about this trial

What is this clinical trial studying?

A study testing Graded Exercise Therapy Arm (GET) and Experimental: Exercise Therapy (GET) plus Cognitive Behavioural Therapy (CBT) in people with Fatigue and Breast Cancer Female, run by National Cancer Centre, Singapore at 4 sites in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 18 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Dr Ryan Shea YC TAN, MBBS, MRCP(UK), MMed (+65 63065771, ryan.shea.tan.y.c@singhealth.com.sg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Client Satisfaction with Exercise Therapy and Cognitive Behavioural Therapy (CBT) (time frame: Up to 12 months post-enrolment.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07116161, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in